The following nongenetic factors related to pancreatic steatosis could serve as activating events for oncogenic KRAS signaling, contributing to pancreatic steatosis-induced PDAC, with current hypotheses focusing on the roles of inflammatory pathways and the tumor microenvironment (81). Here, KRAS is linked to neoplasm.